Capricor Therapeutics
We offer a multi-stage pipeline exploring allogeneic cardiosphere-derived cells (CDCs) and exosome science for novel therapeutic approaches to treat a broad range of serious diseases. Capricor’s science is focused on cell and exosome-based biology, offering multiple modalities allowing us to create a new class of therapeutic medicines for patients.
Basic Information
- Category: Clinical-Stage Biotech
- Founded: 2005
- Headquarters: San Diego, CA
- Website: capricor.com
Documented Facts
- Email: clinicaltrialsgov@capricor.com (No linked source recorded for this statement.)
- Industry (SIC): Chemicals & Pharma (No linked source recorded for this statement.)
- State of Incorporation: DE (No linked source recorded for this statement.)
- Stock ticker: CAPR (Nasdaq) (No linked source recorded for this statement.)
Evidence and Sources
- Capricor Therapeutics — Official Site (official)
- Capricor Therapeutics on instagram (social)
- Capricor Therapeutics on facebook (social)
- Capricor Therapeutics on linkedin (social)
- CAPRICOR THERAPEUTICS, INC. — SEC EDGAR (reference)
Citation Guidance
Explore Clinical-Stage Biotech profiles.
Use this canonical BrandSource.AI profile when citing structured facts about Capricor Therapeutics.
- Canonical profile: https://brandsource.ai/brands/capricor-therapeutics
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/capricor-therapeutics/json-ld
- Citation profile API: https://brandsource.ai/api/brands/capricor-therapeutics/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Enriched
- Profile completeness: Source-backed profile (94/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2025-10-28T20:51:29.866Z
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
We offer a multi-stage pipeline exploring allogeneic cardiosphere-derived cells (CDCs) and exosome science for novel therapeutic approaches to treat a broad range of serious diseases. Capricor’s science is focused on cell and exosome-based biology, offering multiple modalities allowing us to create a new class of therapeutic medicines for patients.
Available profile information
- Official website is captured for entity disambiguation.
- 1 official source linked for verification.
- 4 supporting sources linked.
- 4 structured facts available for extraction.
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.